A Connecticut pro se plaintiff has been caught—and sanctioned for—attempting to manipulate a court he believed was relying on an Artificial Intelligence tool to reach decisions by hiding instructions directed to the tool in court filings. The court held that the plaintiff’s attempted use of an AI “prompt injection” attack offended the integrity of the […]
About Andrew Liebler
CMMC Phase II is Suspended, but Defense Contractors’ Cybersecurity Obligations are Not
The Department of Defense (“DOD”) has announced the immediate suspension of the Cybersecurity Maturity Model Certification (CMMC) Phase II requirements, which were scheduled to take effect on November 10, 2026. This announcement is significant because, as we noted in our prior advisory, Phase II was expected to move CMMC toward more formal assessment requirements for […]
DOJ Settles False Claims Act Case with LOGZONE Over Cybersecurity Deficiencies
On June 18, 2026, the United States Department of Justice (DOJ) announced that it had reached a settlement with defense contractor LOGZONE, Inc. (LOGZONE) in which the company agreed to pay $507,144 to resolve its liability under the False Claims Act (FCA) for allegedly failing to comply with cybersecurity requirements. LOGZONE provides logistics, medical, training, […]
DOJ Cybersecurity Enforcement Pace Shows No Signs of Slowing Down Going Into 2026
As 2025 drew to a close, the United States Department of Justice (DOJ) announced significant developments in cases relating to the allegedly deficient cybersecurity practices of two Department of Defense (DoD) contractors. These two cases suggest that the federal government will continue to make DFARS 7012 compliance for companies that process Controlled Unclassified Information (CUI) […]
DOJ Settles Cyber Qui Tam Action Against Illumina for Allegedly Unsecured Genomic Sequencing Products
On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina) to resolve alleged False Claims Act (FCA) violations related to cybersecurity vulnerabilities and shortcomings in its genomic sequencing products. Of the total settlement, $1.9 million will be paid to the qui tam whistleblower who brought […]